Vishal Verma from 1445 Surprise St, Floral Park, NY 11003, age 52, Phone: (516) 355-5664

Professional Records

Medicine Doctors

Dr. Vishal Verma, Brooklyn NY - MD (Doctor of Medicine)

View page

Specialties:

Internal Medicine

Address:

BROOKLYN HOSPITAL CENTER
121 Dekalb Ave, Brooklyn, NY 11201
(718) 250-8000 (Phone), (718) 250-6124 (Fax)

Ambulatory Internal Medicine
10615 N Hayden Rd Suite 100, Scottsdale, AZ 85260
(480) 998-3990 (Phone)

Southside Phys Ntwrk Hsptlsts
200 Medical Park Blvd, Petersburg, VA 23805
(804) 765-5991 (Phone)

Languages:

English

Hospitals:

BROOKLYN HOSPITAL CENTER
121 Dekalb Ave, Brooklyn, NY 11201

Southside Phys Ntwrk Hsptlsts
200 Medical Park Blvd, Petersburg, VA 23805

Ambulatory Internal Medicine
10615 N Hayden Rd Suite 100, Scottsdale, AZ 85260

Brooklyn Hospital Center at Downtown
121 Dekalb Avenue, Brooklyn, NY 11201

Vishal Verma, New York NY - LAC

View page

Specialties:

Acupuncture

Address:

130 5Th Ave, New York, NY 10011
(206) 618-6230 (Phone)

Languages:

English

Vishal Verma

View page

Specialties:

Radiology

Work:

Stat Radiology
13280 Evening Crk Dr S STE 110, San Diego, CA 92128
(858) 546-3800 (phone), (858) 546-3900 (fax)

Education:

Medical School
University of Miami, Miller School of Medicine
Graduated: 1998

Languages:

English

Description:

Dr. Verma graduated from the University of Miami, Miller School of Medicine in 1998. He works in San Diego, CA and specializes in Radiology.

Vishal Verma, Brooklyn NY

View page

Specialties:

Internal Medicine

Work:

The Brooklyn Hospital
121 Dekalb Ave, Brooklyn, NY 11201
Southside Hospitalist Group
200 Medical Park Blvd, Petersburg, VA 23805

Education:

Kasturba Medical College Manipal

Resumes

Logistics Management Professional With Diverse Experience

View page

Position:

Business Management Analyst at Estes Express Lines

Location:

Richmond, Virginia

Industry:

Logistics and Supply Chain

Work:

Estes Express Lines - Richmond, Virginia Area since Jul 2010
Business Management Analyst
Smithfield Packing Company Nov 2009 - Apr 2010
Brand Evaluation Project (William & Mary Field Consultancy Program)
Ball Corporation Nov 2009 - Apr 2010
Lean Process Improvement Project (William & Mary Consulting Project)
Bainbridge Inc. May 2009 - Jul 2009
Marketing Intern
Gainer Industries, Incorporated May 2009 - Jul 2009
Research Intern (Part-Time)

Education:

The College of William and Mary 2008 - 2010
Training Ship Chanakya, University of Mumbai 1999 - 2002

Skills:

B2B Marketing
Business Process Design
Shipping
Logistics
Supply Chain Management
Process Improvement
Supply Chain
Customer Relationship Management
Final Mile Logistics
Less-Than-Truckload (LTL)
Lean Six Sigma
Financial & Operational Modeling
Operations Management
Six Sigma

Honor & Awards:

1) Awarded National Talent Search Certificate by Central Institute of General knowledge Learning. 2) Certified in Medical First Aid, Fire Fighting, Radar Operation, & Maritime Communication. 3) Licensed as 2nd Mate (Foreign Going Ship) issued by Ministry of Shipping, Government of India. 4) Certified in Safety Management on Oil-tankers and Bridge Team Management.

Vishal Verma

View page

Vishal Verma

View page

Northgate High School

View page

Work:

Northgate High School

Vishal Verma

View page

Vishal Verma

View page

Vishal Verma

View page

Vishal Verma

View page

Publications

Us Patents

5'-Substituted Nucleoside Derivatives And Methods Of Use Thereof For The Treatment Of Viral Diseases

View page

US Patent:

20140235567, Aug 21, 2014

Filed:

Jul 10, 2012

Appl. No.:

14/232540

Inventors:

Vishal A. Verma - Jersey City NJ, US
Ashok Arasappan - Bridgewater NJ, US
F. George Njoroge - Carmel IN, US
Vinay Girijavallabhan - Denville NJ, US
Stephane L. Bogen - Somerset NJ, US
Qun Dang - Westfield NJ, US
David B. Olsen - Lansdale PA, US

International Classification:

C07H 19/14
A61K 45/06
A61K 31/7056
A61K 31/7064

US Classification:

514 49, 536 272, 536 267

Abstract:

The present invention relates to 5′-Substituted Nucleoside Derivatives of Formula (I): (I) and pharmaceutically acceptable salts thereof, wherein B, X, Y, Z, R, R, Rand R are as defined herein. The present invention also relates to compositions comprising at least one 5′-Substituted Nucleoside Derivative, and methods of using the 5′-Substituted Nucleoside Derivatives for treating or preventing HCV infection in a patient.

5'-Substituted Nucleoside Analogs And Methods Of Use Thereof For The Treatment Of Viral Diseases

View page

US Patent:

20140221304, Aug 7, 2014

Filed:

Jul 10, 2012

Appl. No.:

14/232536

Inventors:

Vishal A. Verma - Jersey City NJ, US
Ashok Arasappan - Bridgewater NJ, US
F. George Njoroge - Carmel IN, US
Kevin X. Chen - Edison NJ, US

International Classification:

C07H 19/06
C07H 19/16
C07H 19/20
A61K 31/7056
A61K 31/7072
A61K 31/708
A61K 31/7076
A61K 45/06
C07H 19/10
A61K 31/7068

US Classification:

514 48, 536 285, 536 268, 536 2853, 536 2851, 536 2781, 536 267, 514 49, 514 50, 514 51, 514 45

Abstract:

The present invention relates to 5′-Substituted Nucleoside Analogs of Formula (I): and pharmaceutically acceptable salts thereof, wherein B, X, Z, R, R, Rand R are as defined herein. The present invention also relates to compositions comprising at least one 5′-Substituted Nucleoside Analog, and methods of using the 5′-Substituted Nucleoside Analogs for treating or preventing HCV infection in a patient.

Videos & Images